Osimertinib 80mg Tablets are a targeted cancer therapy used primarily in the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations. Manufactured/handled under quality pharmaceutical standards, Cordium Pharmaceuticals Pvt Ltd supplies and exports high-quality Osimertinib tablets to global markets with reliable logistics support.
We ensure consistent availability and timely export services to countries including:
United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.
Uses of Osimertinib 80mg Tablets
Osimertinib is a third-generation EGFR tyrosine kinase inhibitor (TKI) used for:
Treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC)
First-line therapy for metastatic lung cancer patients
Treatment after progression on earlier EGFR-TKI therapy
Management of T790M mutation-positive NSCLC
Dosage Information
The standard recommended dosage is 80 mg once daily
Should be taken orally, with or without food
Dosage may vary based on patient condition and oncologist recommendation
Always follow strict medical supervision for usage
Note: Dosage should only be determined by a qualified healthcare professional.
Possible Side Effects
Like all targeted therapies, Osimertinib may cause side effects, including:
Diarrhea
Rash or skin dryness
Loss of appetite
Fatigue
Nausea
Dry skin
Decreased blood cell counts
Rare: lung inflammation (interstitial lung disease), heart rhythm changes
Immediate medical attention is advised if severe reactions occur.
Global Export & Supply by Cordium Pharmaceuticals Pvt Ltd
Cordium Pharmaceuticals Pvt Ltd is a trusted pharmaceutical exporter based in India, supplying oncology and life-saving medicines globally with strong compliance and logistics support.
We provide fast and reliable export support to:
USA | UK | Germany | Netherlands | UAE | Brazil | South Africa and more
Contact Information
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
